{{Drugbox
| IUPAC_name = 1-phenylethylhydrazine
| image = Mebanazine.svg
| width = 150px

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 65-64-5
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 6179
| ChEMBL = 1909283
| ChemSpiderID = 5944
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Z5R55CJ4CG

<!--Chemical data-->
| C=8 | H=12 | N=2 
| molecular_weight = 136.19 g/mol
}}

'''Mebanazine''' (trade name '''Actomol''') is a [[monoamine oxidase inhibitor]] (MAOI) of the [[hydrazine]] [[chemical class]] that was previously used as an [[antidepressant]] in the 1960s, but has since been [[withdrawn drug|withdrawn]] due to [[hepatotoxicity]].<ref name="pmid5889715">{{cite journal | author = Gilmour SJ | title = Clinical trial of mebanazine--a new monoamine oxidase inhibitor | journal = The British Journal of Psychiatry | volume = 111 | issue = 478 | pages = 899–902 |date=September 1965 | pmid = 5889715 | doi = 10.1192/bjp.111.478.899| url = }}</ref><ref name="pmid5320546">{{cite journal |vauthors=Barker JC, Jan IA, Enoch MD | title = A controlled trial of mebanazine ('Actomol') in depression | journal = The British Journal of Psychiatry | volume = 111 | issue = 480 | pages = 1095–100 |date=November 1965 | pmid = 5320546 | doi = 10.1192/bjp.111.480.1095| url = }}</ref><ref name="pmid5327282">{{cite journal | author = Knott F | title = A preliminary trial of mebanazine in depressive states | journal = The Journal of New Drugs | volume = 5 | issue = 6 | pages = 345–7 | year = 1965 | pmid = 5327282 | doi = 10.1002/j.1552-4604.1965.tb00259.x| url = http://jcp.sagepub.com/cgi/pmidlookup?view=long&pmid=5327282}}</ref>

== See also ==
* [[Hydrazine (antidepressant)]]

== References ==
{{reflist|30em}}

{{Antidepressants}}
{{Anxiolytics}}
{{Monoamine metabolism modulators}}
{{Hydrazines}}

[[Category:Hepatotoxins]]
[[Category:Hydrazines]]
[[Category:Monoamine oxidase inhibitors]]
[[Category:Withdrawn drugs]]


{{nervous-system-drug-stub}}